Skip to main content
Clinical Trials/2024-515965-32-00
2024-515965-32-00CompletedPhase 2

Randomised, double-blind study comparing the analgesic efficacy of a lidocaine-prilocaine combination with lidocaine alone as local anesthesia for dental procedures in participants with MC1R mutation

Pharmavax AS1 site in 1 country22 target enrollmentStarted: November 27, 2024Last updated:

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
22
Locations
1
Primary Endpoint
Successful pulpal anaesthesia measured by two consecutive 64/64 readings without any participant response, within 10 min with an electric pulp tester.

Study Overview

Brief Summary

To investigate the analgesic efficacy of a lidocaine-prilocaine combination compared to lidocaine alone in dental procedures.

Eligibility Criteria

Ages
18 years to 65+ years (65+ Years, 18-64 Years)
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Participants aged ≥18 and ≤
  • Written informed consent to participate in the study.
  • Participants with red hair or with at least one parent and/or grandparent with red hair and/or genetic sibling from same parents with red hair.

Exclusion Criteria

  • History or presence of hypersensitivity or allergy to lidocaine (or prilocaine or other local anesthetics (amid type or sodium metabisulfite), a history of anaphylactic or anaphylactoid reactions, or a history of other allergy that, in the opinion of the investigator, contraindicates participation.
  • Participants with known thyrotoxicosis.
  • Participants with severe heart disease, including tachycardia.
  • Local infection in the area of injection.
  • Participants with congenital or idiopathic methemoglobinemia.

Outcomes

Primary Outcomes

Successful pulpal anaesthesia measured by two consecutive 64/64 readings without any participant response, within 10 min with an electric pulp tester.

Successful pulpal anaesthesia measured by two consecutive 64/64 readings without any participant response, within 10 min with an electric pulp tester.

Secondary Outcomes

  • Successful pulpal anaesthesia measured by the participants cold sensation during an ice test applied to the treated area.
  • Subject’s assessment of successful soft tissue anaesthesia (yes/no) during a standard pocket procedure.
  • Participant experience of anaesthesia on a scale from 1-5.

Investigators

Sponsor
Pharmavax AS
Sponsor Class
Pharmaceutical company
Responsible Party
Principal Investigator
Principal Investigator

Co-ordinating investigator

Scientific

Pharmavax AS

Study Sites (1)

Loading locations...

Similar Trials